hi all,
I first came here in March 2018 after having a PSA of 38 and being diagnosed as Gleason 4:5
I have been on hormone therapy Since April 2018, had 20 fractions of radiotherapy in August 2018 and received my last triptorelin HT injection in July 2019. At my review in July my PSA was less than 0.1 or, as the nurse called it undetectable. I have now been off the hormone therapy for a little over two weeks and my last review 10 days ago my PSA was still 0.1
My oncologist agreed that taking into account how well I had responded to the hormone and RT therapy and my low PSA level she agreed I could stop my therapy at the 18 month point.
I had read in lots of US medical journals that the way of thinking now is taking into account quality of life and low comparable risk of stopping hormone therapy at 18 months instead of three years, 18 months could soon become the standard.
Even looking at this logically I know my next PSA check and review in March 2020 is going to be a pivotal moment in my recovery from prostate cancer. I have been told that if my PSA in March is above 2.0 there may have to be a reassessment of my treatment.
If it’s under 2.0 then they will just keep me under observation at my four monthly PSA checks for the next couple of years.
I just thought I would update everyone That despite being in the Gleason nine club there can be light at the end of the tunnel. Having had 20 full strength fractions of radiotherapy I also have minimal side-effects and I am well aware that I have been lucky in this case as well, but I also owe a lot to the Bristol haematology and oncology Centre for their excellent care and treatment .
I wish everyone on this forum all the best with the treatment at whatever stage you are